| USD millions | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | Trend | YoY |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Cost of revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Gross profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Research & development | 6.7 | 10.0 | 6.6 | 6.9 | 7.7 | 5.9 | −23.0% | |
| Selling, general & administrative | 3.2 | 5.3 | 6.0 | 6.3 | 7.7 | 6.5 | −16.2% | |
| Selling & marketing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Operating expenses | 9.9 | 15.3 | 12.6 | 13.2 | 15.4 | 12.4 | −19.6% | |
| Operating income | (9.9) | (15.3) | (12.6) | (13.2) | (15.4) | (12.4) | +19.6% | |
| Interest expense | 0.0 | 0.6 | 0.8 | 0.8 | 0.1 | 0.0 | −86.1% | |
| Interest income | 0.0 | 0.2 | 0.3 | 0.0 | 0.0 | 0.2 | +3903.1% | |
| Other income / expense | 0.0 | (0.4) | (0.5) | (3.1) | (0.1) | 0.2 | +415.1% | |
| Pre-tax income | (9.8) | (15.7) | (13.0) | (16.3) | (15.5) | (12.2) | +21.3% | |
| Income tax | (0.0) | 0.0 | 0.6 | (1.6) | (0.1) | (0.2) | −214.7% | |
| Net income | (9.8) | (15.7) | (13.6) | (14.6) | (15.4) | (12.0) | +22.4% | |
| Discontinued operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Other net income adjustments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| EPS, basic (per share) | (7.87) | (11.42) | (9.56) | (8.99) | (6.94) | (4.13) | +40.5% | |
| EPS, diluted (per share) | (7.87) | (11.42) | (9.56) | (8.99) | (6.94) | (4.12) | +40.6% | |
| EBITDA | (9.8) | (15.1) | (12.1) | (15.3) | (15.3) | (12.1) | +20.9% | |
| Depreciation & amortization | 0.1 | 0.1 | 0.1 | 0.2 | 0.1 | 0.1 | −29.6% | |
| Weighted average shares (shares) | 1,249,000 | 1,375,000 | 1,427,000 | 1,627,000 | 2,220,000 | 2,898,000 | +30.5% | |
| Weighted average diluted shares (shares) | 1,249,296 | 1,375,147 | 1,427,220 | 1,627,145 | 2,220,981 | 2,900,202 | +30.6% |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
